昌图有算卦准的地方吗(高阳哪儿算命准) (今日更新中)

BEIJING, Sept. 10 (Xinhua) -- China will start "overall and thorough" safety checks on offshore oil exploration and production to eliminate risks in the wake of oil spills in the country's northern Bohai Bay, the work safety authority said Saturday.The checks, which starts from September 10 to December 10, will be applied to all offshore oil exploration and production, the State Administration of Work Safety said in a circular addressed to oil companies on its website.The companies include China National Petroleum Corporation, China Petrochemical Corporation, China National Offshore Oil Corporation, ConocoPhillips China, Kerr-McGee China Petroleum Ltd., Roc Oil (Bohai) Company, CACT Operators Group, Husky Oil China Ltd., Shanghai Petroleum Co., Energy Development Corporation (EDC) China and Tincy Group Energy, the statement said.The administration urged these enterprises to conduct self-examinations on their offshore fixed and mobile platforms and floating production storage and offloading units, submarine pipelines and onshore oil terminals in two months till November 10. They should file result reports before November 20.The authority's officials, joined by experts, will launch inspections from late November, the statement said. The checks cover well control amid drilling operation, safety management during production, facilities, and management over extreme weather, it added.The order came after the State Council on Wednesday called for strengthened monitoring and management of the marine environment as well as safety checks over the country's ocean oil fields to toughen safety measures and erase potential risks.The decision was made after oil spills at an offshore oil field run by U.S. oil giant ConocoPhillips have polluted more than 5,500 square km of sea water in the Bohai Bay since June.The central government also imposed restricts on new petrochemical projects and ban reclamation projects in the bay for environmental concerns.China has stepped up efforts to explore and materialize offshore resources to seek more dependence of the marine industries as a strategic development move. In its 12th Five-Year Plan, the government advocates greater scientific and systematic utilization of marine resources and coastal areas as energy demand soars.

HELSINKI, Aug. 21 (Xinhua) -- The Finnish company Spektikor has recently developed a novel type of disposable heart rate indicator, local media reported on Sunday.Different from a conventional heart rate monitor, it is a speed heart rate indicator designed for first aid professionals and specially used in first aids in major accidents, disasters and other crises.According to Spektikor, the product is consisted of a heart rate sensor with two EKG electrodes and a LED indicator, which are connected by a 35-cm-long wire.In operation, the sensor is placed on a patient's chest and the LED indicator is sticked to the patient's cheek. If the heart rate is within the normal range, the LED indicator will flash green with each beat. If the heart rate is dangerously low or high, the light will turn red.The product will help hospital staff speed up their work considerably as it is not necessary to check the pulse manually. In addition to saving time, it will also enhance safety, as the LED indicator can be seen clearly at a glance.The market prospect of the disposable heart rate indicator is quite optimistic as there is a worldwide need for the product.

URUMQI, Sept. 5 (Xinhua) -- The first China-Eurasia Expo that concluded Monday in Urumqi, capital of northwest China's Xinjiang Uygur Autonomous Region, has clinched trade and technical cooperation contracts worth about 130 billion U.S. dollars, expo organizer said.Among all contracts, 5.5 billion dollars are clinched between Chinese and foreign companies, while 124 billion dollars are among Chinese companies, the organizer said.About 50,000 officials and business people from China and about 30 countries, regions and international organizations attended the trade fair, which also attracted an audience of more than 300,000 people.The event was upgraded from the 19-year-old China Urumqi Foreign Economic Relations and Trade Fair, a regional trade fair, last year.The fair covered an area of nearly 80,000 square meters for its more than 4,000 exhibition booths, according to the organizer.

WASHINGTON, Aug. 11 (Xinhua) -- The unique fossils of an adult plesiosaur and its unborn baby may provide the first evidence that these ancient animals gave live birth like mammals, according to a new study to be published Friday in the journal Science.The 78-million-year-old, 15.4-foot-long (4.7-meter-long) adult specimen is a Polycotylus latippinus, one of the giant, carnivorous, four-flippered reptiles that lived during the Mesozoic Era.Dr. Robin O'Keefe of Marshall University in West Virginia and Dr. Luis Chiappe, Dinosaur Institute director of the Natural History Museum in Los Angeles County, have determined that it is the fossil of an embryonic marine reptile contained within the fossil of its mother.The embryonic skeleton contained within shows much of the developing body, including ribs, 20 vertebrae, shoulders, hips, and paddle bones.O'Keefe and Chiappe have also determined that plesiosaurs were unique among aquatic reptiles in giving birth to a single, large offspring, and that they may have lived in social groups and engaged in parental care.Although live birth has been documented in several other groups of Mesozoic aquatic reptiles, no previous evidence of it has been found in the important order of plesiosaurs."Scientists have long known that the bodies of plesiosaurs were not well suited to climbing onto land and laying eggs in a nest," O'Keefe said."So the lack of evidence of live birth in plesiosaurs has been puzzling. This fossil documents live birth in plesiosaurs for the first time, and so finally resolves this mystery."

BEIJING, Sept. 14 (Xinhuanet) -- The U.S. Food and Drug Administration (FDA) on Monday announced a recall on a drug infusion pump of Medtronic, the Associated Press reported.The recalled drug pump was called "SynchroMed II", including models of 8637-20 and 8637-40, distributed between 2004 and July 2011.Drug infusion pump was used to deliver the drugs for patients to treat chronic pain, spasms as well as other conditions.The pumps' malfunction could put patients in the risk of either recurrent or withdrawal symptoms, which could be life-threatening, FDA warned.There were 55 reported cases and one death related to the drug withdrawal, among a total 139,653 SynchroMed II pump implants worldwide, FDA notified.The problem was due to a film within the pump's battery that could stop the therapy, FDA said.Medtronic, the U.S. medical technology company based in Minneapolis, is not recommending patients to remove the pumps, but instead, encourage patients to contact their doctor if they hear the device alarm.

来源：资阳报